What is MicroForce?
MicroForce operates at the intersection of health-tech and preventative medicine, specializing in the identification and mitigation of contagious pathogens. The company distinguishes itself by focusing on the invisible threats that permeate daily environments, utilizing a data-driven methodology to foster public awareness and safety. By positioning itself as a critical layer in the defense against infectious diseases, MicroForce addresses a growing global demand for proactive health monitoring and sanitation intelligence. Its market position is defined by a unique blend of diagnostic awareness and strategic intervention, aiming to reduce the transmission rates of harmful germs in high-traffic public and private spaces.
How much funding has MicroForce raised?
MicroForce has raised a total of $16K across 1 funding round:
Debt
$16K
Debt (2021): $16K with participation from PPP
Key Investors in MicroForce
PPP
Public-Private Partnership
What's next for MicroForce?
With the recent capital secured, MicroForce is expected to prioritize the scaling of its core technology stack and the expansion of its operational infrastructure. The company's strategic roadmap likely involves deepening its research and development capabilities to enhance the precision of its threat-detection systems. Furthermore, the firm is poised to explore new partnerships within the public health and commercial facility management sectors to integrate its solutions into broader safety protocols. As MicroForce navigates this Series A/B growth stage, the focus will remain on achieving sustainable market penetration and establishing itself as a leader in the preventative health technology landscape. Future milestones will likely center on product diversification and the refinement of its proprietary germ-mitigation frameworks to meet evolving global health standards.
See full MicroForce company page
